Zobrazeno 1 - 10
of 10 123
pro vyhledávání: '"Cutler JA"'
Autor:
Kwon MC; Discovery Oncology, Janssen R&D, Beerse, Belgium., Thuring JW; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Querolle O; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Dai X; Discovery Product Development and Supply, Janssen R&D, Shanghai, China., Verhulst T; Discovery Oncology, Janssen R&D, Beerse, Belgium., Pande V; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Marien A; Discovery Oncology, Janssen R&D, Beerse, Belgium., Goffin D; Discovery Oncology, Janssen R&D, Beerse, Belgium., Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Jin C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Shaffer PL; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Jacobs F; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Vinken P; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Cai W; Discovery Product Development and Supply, Janssen R&D, Shanghai, China., Keersmaekers V; Discovery Oncology, Janssen R&D, Beerse, Belgium., Eyassu F; Discovery Oncology, Janssen R&D, Beerse, Belgium., Bhogal B; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Verstraeten K; Discovery Oncology, Janssen R&D, Beerse, Belgium., El Ashkar S; Discovery Oncology, Janssen R&D, Beerse, Belgium., Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Jayaguru P; Translational Research, Janssen R&D, Spring House, PA., Barreyro L; Translational Research, Janssen R&D, Spring House, PA., Kuchnio A; Discovery Oncology, Janssen R&D, Beerse, Belgium., Darville N; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Krosky D; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Urbanietz G; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Verbist B; TMEDS, Janssen R&D, Beerse, Belgium., Edwards JP; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Cowley GS; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Kirkpatrick R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Steele R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Ferrante L; Early Development, Janssen R&D, Spring House, PA., Guttke C; Translational Research, Janssen R&D, Spring House, PA., Daskalakis N; Early Development, Janssen R&D, Spring House, PA., Pietsch EC; Discovery Oncology, Janssen R&D, Spring House, PA., Wilson DM; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Attar R; Translational Research, Janssen R&D, Spring House, PA., Elsayed Y; Discovery Oncology, Janssen R&D, Spring House, PA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Packman K; Early Development, Janssen R&D, Cambridge, MA., Philippar U; Discovery Oncology, Janssen R&D, Beerse, Belgium.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1206-1220.
Autor:
Bourgeois W; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Cutler JA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Aubrey BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wenge DV; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Perner F; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Internal Medicine C, University Medicine Greifswald, Greifswald, Germany., Martucci C; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Henrich JA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Klega K; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Boileau M; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Wen Y; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Hatton C; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Apazidis AA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Olsen SN; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Kirmani N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA., Pikman Y; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Pollard JA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Perry JA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Howard Hughes Medical Institute, Boston, MA., McGeehan GM; Syndax Pharmaceuticals, Waltham, MA., Crompton BD; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Armstrong SA; Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA.
Publikováno v:
Blood [Blood] 2024 Apr 11; Vol. 143 (15), pp. 1513-1527.
Publikováno v:
In ACC Current Journal Review 2004 13(7):60-60
Autor:
Tsai JM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Aguirre JD; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Li YD; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Molecular & Cellular Biology, Harvard University, Cambridge, MA, USA., Brown J; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Focht V; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Kater L; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Kempf G; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Sandoval B; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schmitt S; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Rutter JC; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Galli P; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; Faculty of Science, University of Basel, Basel, Switzerland., Sandate CR; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Cutler JA; Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Zou C; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Lumpkin RJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Cavadini S; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Park PMC; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sievers Q; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hatton C; Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ener E; Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Regalado BD; Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sperling MT; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Słabicki M; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kim J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Zon R; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Zhang Z; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Miller PG; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Belizaire R; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sperling AS; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Irizarry R; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Armstrong SA; Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. Electronic address: nicolas.thoma@fmi.ch., Ebert BL; Division of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA. Electronic address: benjamin_ebert@dfci.harvard.edu.
Publikováno v:
Molecular cell [Mol Cell] 2023 Aug 03; Vol. 83 (15), pp. 2753-2767.e10. Date of Electronic Publication: 2023 Jul 20.
Autor:
Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pugsley HR; Luminex Corporation, Seattle, Washington, USA., Bennington R; Hematologics Inc., Seattle, Washington, USA., Fritschle W; Hematologics Inc., Seattle, Washington, USA., Hartmann L; Hematologics Inc., Seattle, Washington, USA., Zaidi N; Hematologics Inc., Seattle, Washington, USA., Menssen AJ; Hematologics Inc., Seattle, Washington, USA., Singleton TP; Hematologics Inc., Seattle, Washington, USA., Xu D; Hematologics Inc., Seattle, Washington, USA., Loken MR; Hematologics Inc., Seattle, Washington, USA., Wells DA; Hematologics Inc., Seattle, Washington, USA., Brodersen LE; Hematologics Inc., Seattle, Washington, USA., Zehentner BK; Hematologics Inc., Seattle, Washington, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Mar; Vol. 104 (2), pp. 183-194. Date of Electronic Publication: 2021 Nov 13.
Autor:
Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.; Internal Medicine C, University Medicine Greifswald, Greifswald, Germany., Stein EM; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Singh S; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kim J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Apazidis A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Rahnamoun H; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Anand D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.; Internal Medicine C, University Medicine Greifswald, Greifswald, Germany., Marinaccio C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Wen Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schaller D; In silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Mowla S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xiao W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Hematopathology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gamlen HA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stonestrom AJ; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Persaud S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ener E; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Doench JG; Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA., McGeehan GM; Syndax Pharmaceuticals, Waltham, MA, USA., Volkamer A; In silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Chodera JD; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Levine RL; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. leviner@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. leviner@mskcc.org., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. scott_armstrong@dfci.harvard.edu., Cai SF; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. cais1@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. cais1@mskcc.org.
Publikováno v:
Nature [Nature] 2023 Mar; Vol. 615 (7954), pp. 913-919. Date of Electronic Publication: 2023 Mar 15.
Autor:
Cutler JA; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02210, USA., Udainiya S; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.; Center for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bangalore, Karnataka, 560 029, India., Madugundu AK; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.; Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, 560 066, India.; Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India., Renuse S; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA., Xu Y; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, State Key Laboratory of Medical Molecular Biology, 100005, Beijing, China., Jung J; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Departments of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, 17104, Republic of Korea., Kim KP; Departments of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, 17104, Republic of Korea.; Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, 02453, Republic of Korea., Wu X; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA., Pandey A; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. Pandey.Akhilesh@mayo.edu.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Pandey.Akhilesh@mayo.edu.; Center for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bangalore, Karnataka, 560 029, India. Pandey.Akhilesh@mayo.edu.
Publikováno v:
Leukemia [Leukemia] 2020 Jan; Vol. 34 (1), pp. 301-305. Date of Electronic Publication: 2019 Aug 09.
Autor:
Cushman WC; Department of Preventive Medicine, University of Tennessee Health Science Center, and Medical Service, Veterans Affairs Medical Center, Memphis (W.C.C.)., Ringer RJ; Department of Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM (R.J.R.)., Rodriguez CJ; Departments of Medicine, Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.J.R.)., Evans GW; Department of Biostatistics and Data Science (G.W.E.), Wake Forest School of Medicine, Winston-Salem, NC., Bates JT; Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center and Department of Medicine, Baylor College of Medicine, Houston, TX (J.T.B.)., Cutler JA; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (J.A.C.)., Hawfield A; Department of Internal Medicine, Section on Nephrology (A.H.), Wake Forest School of Medicine, Winston-Salem, NC., Kitzman DW; Department of Internal Medicine, Sections on Cardiovascular Medicine and Geriatrics (D.W.K.), Wake Forest School of Medicine, Winston-Salem, NC., Nasrallah IM; Department of Radiology, University of Pennsylvania, Philadelphia (I.M.N.)., Oparil S; Vascular Biology and Hypertension Program, Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham (S.O.)., Nord J; Department of Internal Medicine, University of Utah School of Medicine and Internal Medicine Service, George E. Wahlen Veterans Affairs Medical Center, Salt Lake City (J.N.)., Papademetriou V; Medical Service, Veterans Affairs Medical Center and Georgetown University, Washington, DC (V.P.)., Servilla K; Research Service, New Mexico Veterans Affairs Health Care System, Albuquerque (K.S.)., Van Buren P; Department of Internal Medicine, University of Texas Southwestern Medical Center and Medical Service, Veterans Affairs Medical Center, Dallas, TX (P.V.B.)., Whelton PK; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W.)., Whittle J; Division of Medicine, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, WI (J.W.)., Wright JT Jr; Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, OH (J.T.W.).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2022 Sep; Vol. 79 (9), pp. 2071-2080. Date of Electronic Publication: 2022 Jun 29.
Autor:
Hemming ML; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Benson MR; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Loycano MA; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Anderson JA; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Andersen JL; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Taddei ML; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Krivtsov AV; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Aubrey BJ; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Cutler JA; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Hatton C; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Sicinska E; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Armstrong SA; Department of Pediatric Oncology and Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Jul 06; Vol. 12 (7), pp. 1804-1823.
Autor:
Aubrey BJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bourgeois W; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Gu S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perlee S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Internal Medicine C, Universitaetsmedizin Greifswald, Greifswald, Germany., Rahnamoun H; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Theall ACP; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Henrich JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zhu Q; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA., Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Kim YJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cremer A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Hematology-Oncology, University Hospital Frankfurt, Frankfurt/Main, Germany.; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany., Olsen SN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Eleuteri NA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA., McGeehan GM; Syndax Pharmaceuticals, Waltham, MA, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Liu XS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. scott_armstrong@dfci.harvard.edu.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA. scott_armstrong@dfci.harvard.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2022 May; Vol. 3 (5), pp. 595-613. Date of Electronic Publication: 2022 May 09.